Abstract
Program Description:
Human papillomavirus (HPV)–related oropharyngeal cancer is now recognized as a clinically distinct entity, and data describing the nature of the epidemic, optimal treatment strategies, and survival outcomes are rapidly developing. Our patients are asking pertinent questions about HPV transmission, the role of vaccination, and monitoring recommendations. This miniseminar will update practitioners on the accuracy of testing, how to counsel patients and families regarding the nature of HPV infection (risk and transmissibility), vaccination, the management of benign lesions, and surveillance. This panel will appeal broadly to trainees, general otolaryngologists, and head and neck surgical oncologists.
Educational Objectives:
(1) Advise patients and partners regarding HPV infection and transmission. (2) List the Centers for Disease Control and Prevention recommendations for HPV vaccination. (3) Develop a surveillance plan for patients with HPV and their families.
Get full access to this article
View all access options for this article.